Your browser does not support JavaScript or JavaScript was disabled. StartupTree may not work correctly without JavaScript.

Temple Tech Commercialization Portfolio 2021

Temple Tech Commercialization Portfolio 2021

Over 520 Million dollars raised!

29 Portfolio Companies!

Temple University actively places its technology into newly formed entities commonly called spinouts or startups. Our model for the creation of new companies is intended to enable the most efficient mechanism of moving a technology forward toward commercialization to secure investment only when the technology is significantly de-risked. Our process focuses on capital efficiency and resource identification. Temple’s New Venture model is designed to use seed and angel funding in combination with early engagement with a strategic partner.
Explore Portfolio
Research Innovation at Temple University

$520 Million Raised | 29 Portfolio Companies

Read the report

Therapeutic

Unmet medical needs remain a major driver in new company formation at Temple University. Included in those are companies focused on developing new therapeutic interventions. These technologies have emerged from around our campus, including those from the Lewis Katz School of Medicine to those from our School of Pharmacy as well as those from our College of Science and Technology. These technologies range from using CRISPR based approach to treat infectious diseases, to gene therapy for heart disease, and small molecules for autoimmunity and diabetes, and even bacterial metabolites to change the course of psoriasis. We even have a company making synthetic antibodies that will be used to detect and potentially treat infectious diseases.
Explore more therapeutic startups

Medical Devices

New medical devices need to save lives, time, and/ or money. We at are proud to note that the medical device technologies emerging from Temple University have the potential to do all three! Temple has benefited from innovative physicians and engineers and quality entrepreneurs who have identified designers and manufactures to move these concepts towards (or to) commercialization. Technologies ranging from clot busting catheters, to a needle and sharps finding device used during surgery, as well as an aqueous soy skin concept that may revolutionize wound care.
Explore more medical devices

Software

Typically, software is licensed directly to existing companies. However, in some cases the concepts explore a brand-new approach to solving a societal problem. Temple University’s software spinouts certainly represent such novel solutions. We are is pleased to note the diverse array of software companies in our spinout portfolio. Ranging from software to diagnose and treat balance issues, to educational programs, as well as deploying a novel approach to managing patients with COPD at home and helping caregivers improve the lives of children with autism.
Explore more software startups

Research Tools / Clean Tech

Investigators develop technologies and methods to solve problems in their own research. Sometimes those solution have a marketplace waiting for them. Such is the case for our cell line generating method from School of Pharmacy. Other solutions emerging from Temple have the potential to make our world cleaner and safer, we are hope these and other clean tech companies emerging from Temple University have such an impact.
Explore more startups